Join Now

Utah Life Sciences Companies' COVID-19 News

May 5, 2020
AdvaMed Request for Tariff Exclusions for Medical Technology Products

The Advanced Medical Technology Association (AdvaMed) has consistently indicated that the United States should not be imposing tariffs on medical technology. USTR’s moves in that direction are welcome. We are grateful to USTR for its recent decision to grant exclusions for a range of personal protective equipment (PPE) imports from China. This action could help […]

March 20, 2020
Teva to Donate Potential COVID-19 Treatment, Hydroxychloroquine Sulfate Tablets to Hospitals Nationwide

Teva will donate 6 Million tablets through wholesalers to hospitals by March 31, and more than 10 Million within a month TEL AVIV, Israel & PARSIPPANY, N.J.–(BUSINESS WIRE)– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today the immediate donation of more than 6 million doses of hydroxychloroquine sulfate tablets through wholesalers to hospitals […]

March 17, 2020
BioUtah COVID-19 Life Sciences Survey

TIME SENSITIVE – PLEASE TAKE SURVEY Dear Members of Utah’s Life Sciences Community, BioUtah is taking a multi-pronged approach to support our life sciences companies, industry workforce, and communities during the COVID-19 pandemic, including: Working directly with the Utah State Coronavirus Task Force to identify products and resources needed in the state Indentifing funding sources from […]

March 3, 2020
Co-Diagnostics, Inc. Invited to Speak on Coronavirus at Molecular Med Tri-Con in San Francisco

March 03, 2020 06:30 AM Eastern Standard Time SALT LAKE CITY–(BUSINESS WIRE)–Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests and that recently reported it had received a CE marking for its COVID-19 coronavirus assay, announced today that it has been requested to speak at […]